HHH insider Form 144: 1,360 common shares to be sold via J.P. Morgan

Rhea-AI Filing Summary

Howard Hughes Holdings Inc. (HHH) filing a Form 144 notifies a proposed sale of 1,360 common shares through J.P. Morgan Securities LLC on or about 08/15/2025 with an aggregate market value of $99,946. The shares were acquired as stock awards on 12/14/2017 (274 shares) and 06/15/2018 (1,086 shares) and were granted as compensation. The filing reports 59,401,210 shares outstanding for the class. The filer states there are no undisclosed material adverse facts and reports no securities sold in the past three months.

Insights

Securities Analyst

TL;DR Proposed sale is immaterial to capitalization and reflects routine insider compensation liquidation.

The proposed sale of 1,360 shares, representing roughly 0.0023% of the outstanding common stock, is immaterial to Howard Hughes' market capitalization. The shares were acquired via stock awards in 2017 and 2018 and are being routed through a major brokerage, indicating a standard liquidity event rather than a corporate change. No prior sales in the past three months are reported, and the filer affirms absence of undisclosed material information. For investors, this filing signals insider monetization consistent with compensation vesting, not a material corporate development.

Corporate Governance Expert

TL;DR Compliance filing meets disclosure obligations; no governance red flags evident.

This Form 144 provides required notice for an insider sale tied to historical stock awards. The broker and approximate sale date are disclosed, and the filer certifies no known material nonpublic information, which aligns with standard governance practices. The small size of the transaction relative to outstanding shares reduces regulatory and governance concern. The filing contains no indications of forced liquidation, regulatory action, or governance dispute.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 390 Madison Avenue - 6th Floor New York NY 10017	1360	99946	59401210	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/14/2017	Stock Award	Issuer			274	12/14/2017	Compensation
Common	06/15/2018	Stock Award	Issuer			1086	06/15/2018	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Howard Hughes (HHH) Form 144 report?

The Form 144 reports a proposed sale of 1,360 common shares through J.P. Morgan on or about 08/15/2025, with aggregate market value $99,946.

When and how were the shares being sold acquired?

The shares were acquired as stock awards: 274 shares on 12/14/2017 and 1,086 shares on 06/15/2018, received as compensation.

How large is this sale relative to HHH outstanding shares?

The filing lists 59,401,210 shares outstanding, so the 1,360-share sale is approximately 0.0023% of outstanding common stock.

Did the filer report any recent sales in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Does the filer assert possession of undisclosed material information?

No. By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.